The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic, according to Reuters.

Hardworking Tennesseans have tried changes to diets and exercise to lose weight and maintain healthy lifestyles, but ...

UNAM's Applied Literature Seminar is blending literature and real-world transformation to tackle Mexico's biggest social ...

With the grave health consequences of what is increasingly becoming staple diet overlooked, regulators and the government ...

Obesity has woven itself into the fabric of our nation, threatening the vitality of our youth, the productivity of our ...

Obesity has become a major global problem. Since 1975, the number of overweight people around the world has almost tripled, ...

The study — published recently in the journal Social Science & Medicine — identified three key high school factors linked to ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Gen Alpha (children 14 and younger) led the rise of GLP-1 utilization from 2023 to 2024, with an 85% growth rate in that period. But what is behind the sharp increase? 3 factors at play There are ...

It's been eight years since the drug Ozempic was approved by the FDA for diabetes, and four years since it was approved for ...